MRK vs PFE

Merck & Co. against Pfizer — live side-by-side technical comparison.

Prices as of 2026-11-06T21:03:31+00:00 UTC · updates daily

Who leads right now

MRK leads 4 of the 5 windows we measure — over 1 month MRK is +2.8% and PFE +5.0%; over year to date MRK is +39.4% and PFE +18.0%. The MRK/PFE price ratio stands at 4.9925, below its 50-day average of 5.0972, and above the 200-day average of 4.7431. A ratio above its own average means MRK is gaining on PFE; on this reading the recent edge belongs to PFE.

Performance side by side

MRKPFE
Price$146.73 $29.39
1 day -0.1%lead -1.6%
5 days -1.9%lead -3.7%
1 month +2.8% +5.0%lead
6 months +29.2%lead +10.8%
Year to date +39.4%lead +18.0%
52-week position 86% of range 74% of range
52-week range $85.80–$156.92 $23.62–$31.44
vs 50-day average above $146.36 above $28.74
vs 200-day average above $127.65 above $26.91
RSI (14) 54 50
Next earnings 2026-10-292027-02-02

Where each one stands

MRK — Merck & Co.

MRK trades at $146.73, above its 50-day average of $146.36, and above the 200-day at $127.65. It sits at 86% of its 52-week range ($85.80–$156.92); 14-day RSI is 54, in neutral territory; an average session moves it about 3.6%. For levels, the first level overhead is $150.00 (2.2% away) and the first support below is $146.36 (0.2% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.

PFE — Pfizer

PFE trades at $29.39, above its 50-day average of $28.74, and above the 200-day at $26.91. It sits at 74% of its 52-week range ($23.62–$31.44); 14-day RSI is 50, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $30.00 (2.1% away) and the first support below is $29.21 (0.6% down). On the checklist the page runs for every asset, 3 of 6 checks read bullish — the lean is bullish.

Which one moves harder

MRK is the more volatile of the two — an average session moves it 3.6% against 2.7% for PFE, so an identical position size carries roughly 1.3× the daily risk.

What would change the picture

The comparison turns on those levels: MRK clearing $150.00 or losing $146.36; PFE clearing $30.00 or losing $29.21. Until one of them gives way, the relative reading above stands.

Questions people ask about MRK vs PFE

Which is performing better right now, MRK or PFE?
Over the past month MRK is +2.8% and PFE is +5.0%, so PFE is ahead on that window. Year to date the figures are +39.4% for MRK and +18.0% for PFE.
Is MRK or PFE more volatile?
MRK is the more volatile of the two — an average session moves it 3.6% against 2.7% for PFE, so an identical position size carries roughly 1.3× the daily risk.
What are the key levels for MRK and PFE?
MRK: resistance $150.00, support $146.36; PFE: resistance $30.00, support $29.21. Levels come from recent swing zones and round numbers, recomputed daily.
When do MRK and PFE report next?
MRK: 2026-10-29. PFE: 2027-02-02. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the MRK/PFE ratio mean?
It is simply MRK's price divided by PFE's — 4.9925 today. When the ratio rises, MRK is outperforming; when it falls, PFE is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

MRK →
Merck & Co.
Full technical brief: trend, levels, chart, news
PFE →
Pfizer
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs MRKLLY vs UNHLLY vs TMOAMGN vs LLYGILD vs LLYABT vs LLY